Literature DB >> 15804925

A decade of pre-diagnostic assessment in a case of familial Alzheimer's disease: tracking progression from asymptomatic to MCI and dementia.

A K Godbolt1, L Cipolotti, V M Anderson, H Archer, J C Janssen, S Price, M N Rossor, N C Fox.   

Abstract

Detailed study of the very earliest phases of Alzheimer's disease (AD) is seldom possible, especially those changes preceding the development of mild cognitive impairment (MCI), which may occur years before diagnosis. Knowledge of imaging and neuropsychological features of these early stages would add insight into this poorly understood phase of the disease. We present data from a subject who entered a longitudinal study of individuals at risk of familial Alzheimer's disease (FAD), as a healthy volunteer with no memory complaints, undergoing 12 assessments between 1992 and 2003. Longitudinal MRI, neuropsychological and clinical data are presented over the decade preceding this man's diagnosis, through the asymptomatic and prodromal preludes to his presentation with MCI and on to eventual conversion to AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804925     DOI: 10.1080/13554790490896866

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  8 in total

1.  Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.

Authors:  Liana G Apostolova; Kristy S Hwang; Luis D Medina; Amity E Green; Meredith N Braskie; Rebecca A Dutton; Jeffrey Lai; Daniel H Geschwind; Jeffrey L Cummings; Paul M Thompson; John M Ringman
Journal:  Dement Geriatr Cogn Disord       Date:  2011-09-23       Impact factor: 2.959

Review 2.  Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.

Authors:  Eric M Reiman; Jessica B S Langbaum; Pierre N Tariot
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

3.  Discriminative and predictive power of an informant report in mild cognitive impairment.

Authors:  V Isella; L Villa; A Russo; R Regazzoni; C Ferrarese; I M Appollonio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

4.  Brain structural alterations detected by an automatic quantified tool as an indicator for MCI diagnosing in type 2 diabetes mellitus patients: A magnetic resonance imaging study.

Authors:  Jing Gu; Siyuan Cui; Huihui Qi; Jing Li; Wenjuan Wu; Silun Wang; Jianming Ni; Zengli Miao
Journal:  Heliyon       Date:  2022-05-12

5.  The emergence of cognitive discrepancies in preclinical Alzheimer's disease: a six-year case study.

Authors:  Mark W Jacobson; Dean C Delis; Guerry M Peavy; Spencer R Wetter; Erin D Bigler; Tracy J Abildskov; Mark W Bondi; David P Salmon
Journal:  Neurocase       Date:  2009-04-21       Impact factor: 0.881

6.  Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.

Authors:  Bradford C Dickerson; Reisa A Sperling; Bradley T Hyman; Marilyn S Albert; Deborah Blacker
Journal:  Arch Gen Psychiatry       Date:  2007-12

7.  Prediction and Modeling of Neuropsychological Scores in Alzheimer's Disease Using Multimodal Neuroimaging Data and Artificial Neural Networks.

Authors:  Seyed Hani Hojjati; Abbas Babajani-Feremi
Journal:  Front Comput Neurosci       Date:  2022-01-06       Impact factor: 2.380

8.  Cognitive Test Scores and Progressive Cognitive Decline in the Aberdeen 1921 and 1936 Birth Cohorts.

Authors:  Lawrence J Whalley; Roger T Staff; Helen Lemmon; Helen C Fox; Chris McNeil; Alison D Murray
Journal:  Brain Sci       Date:  2022-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.